BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37417291)

  • 21. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
    Bannon SA; Montiel MF; Goldstein JB; Dong W; Mork ME; Borras E; Hasanov M; Varadhachary GR; Maitra A; Katz MH; Feng L; Futreal A; Fogelman DR; Vilar E; McAllister F
    Cancer Prev Res (Phila); 2018 Nov; 11(11):679-686. PubMed ID: 30274973
    [No Abstract]   [Full Text] [Related]  

  • 24. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
    Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
    J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
    Becker AE; Hernandez YG; Frucht H; Lucas AL
    World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary pancreatic cancer.
    Abe K; Kitago M; Kitagawa Y; Hirasawa A
    Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
    Castro E; Romero-Laorden N; Del Pozo A; Lozano R; Medina A; Puente J; Piulats JM; Lorente D; Saez MI; Morales-Barrera R; Gonzalez-Billalabeitia E; Cendón Y; García-Carbonero I; Borrega P; Mendez Vidal MJ; Montesa A; Nombela P; Fernández-Parra E; Gonzalez Del Alba A; Villa-Guzmán JC; Ibáñez K; Rodriguez-Vida A; Magraner-Pardo L; Perez-Valderrama B; Vallespín E; Gallardo E; Vazquez S; Pritchard CC; Lapunzina P; Olmos D
    J Clin Oncol; 2019 Feb; 37(6):490-503. PubMed ID: 30625039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA2 and pancreatic cancer.
    Naderi A; Couch FJ
    Int J Gastrointest Cancer; 2002; 31(1-3):99-106. PubMed ID: 12622420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
    Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
    Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
    Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
    JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.
    Ghiorzo P; Pensotti V; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bonelli L; Borgonovo G; Bruno W; Gozza A; Gargiulo S; Mastracci L; Nasti S; Palmieri G; Papadia F; Pastorino L; Russo A; Savarino V; Varesco L; Bernard L; Bianchi Scarrà G;
    Fam Cancer; 2012 Mar; 11(1):41-7. PubMed ID: 21989927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
    Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
    J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
    Bennett C; Suguitan M; Abad J; Chawla A
    Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
    Park D; Shakya R; Koivisto C; Pitarresi JR; Szabolcs M; Kladney R; Hadjis A; Mace TA; Ludwig T
    PLoS One; 2019; 14(12):e0226714. PubMed ID: 31877165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis.
    Dal Buono A; Poliani L; Greco L; Bianchi P; Barile M; Giatti V; Bonifacio C; Carrara S; Malesci A; Laghi L
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.
    Downs B; Kim YC; Xiao F; Snyder C; Chen P; Fleissner EA; Becirovic D; Wen H; Sherman S; Cowan KH; Lynch HT; Wang SM
    Breast Cancer Res Treat; 2015 May; 151(1):219-24. PubMed ID: 25833210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer.
    Slater EP; Wilke LM; Böhm LB; Strauch K; Lutz M; Gercke N; Matthäi E; Hemminki K; Försti A; Schlesner M; Paramasivam N; Bartsch DK
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.